Exelixis Inc. (NASDAQ:EXEL) saw an upside of 1.73% to close Monday at $17.02 after adding $0.29 on the day. The 5-day average trading volume is 4,186,800 shares of the company’s common stock. It has gained $17.03 in the past week and touched a new high 5 times within the past 5 days. An average of 2,767,135 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 2,300,880.
EXEL’s 1-month performance is 8.48% or $1.19 on its low of $15.36 reached on 12/29/22. The company’s shares have touched a 52-week low of $14.87 and high of $23.40, with the stock’s rally to the 52-week high happening on 01/06/23. YTD, EXEL has achieved 6.11% or $0.98 and has reached a new high 3 times. However, the current price is down -27.26% from the 52-week high price.
EXEL stock investors last saw insider trading activity on Dec 15.Lamb Peter (EVP, Scientific Strategy & CSO) most recently sold 20,000 shares at $15.88 per share on Dec 15. This transaction cost the insider $317,600. Director, POSTE GEORGE, sold 40,000 shares at a price of $16.68 on Nov 29. Then, on Sep 12, EVP, Commercial Haley Patrick J. sold 40,000 shares at a price of $17.94 per share. This transaction amounted to $717,600.
EXEL stock has a beta of 0.70. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 3.31 while the price-to-book (PB) in the most recent quarter is 2.20, with the price to cash flow ratio at 15.79.
Exelixis Inc.’s quick ratio for the period ended September 29 was 6.00, with the current ratio over the same period at 6.10. In terms of profitability, the gross margin trailing 12 months is 96.60%. The firm’s gross profit as reported stood at $1.38 billion against revenue of $1.43 billion.
For the quarterly period ending September 29 this year, Exelixis Inc.’s cash and short-term investments amounted to $871.71 million against total debt of $159.84 million. Net income and sales went down compared to those figures reported in the previous quarter. Net income grew 47.82% to $73.21 million, while revenue of $70.67 million was 3.47% off the previous quarter. Analysts expected EXEL to announce $0.19 per share in earnings in its latest quarter, but it posted $0.23, representing a 21.10% surprise. EBITDA for the quarter stood at more than $88.28 million. EXEL stock balance sheet for the quarter ending September 29 shows that total liabilities totaled 469.97 million, with total debt at $159.84 million. Shareholders hold equity totaling $322.56 million.
Let’s look briefly at Exelixis Inc. (EXEL) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 23 January was 61.32% to suggest the stock is trending Neutral, with historical volatility in this time period at 22.49%.
The stock’s 5-day moving average is $16.58, reflecting a +3.59% or $0.59 change from its current price. EXEL is currently trading +7.99% above its 20-day SMA, -5.44% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +2.78% and SMA200 by-25.68%.
Stochastic %K and %D was 55.92% and 49.95% and the average true range (ATR) pointed at 0.47. The RSI (14) points at 57.64%, while the 14-day stochastic is at 61.11% with the period’s ATR at 0.48. The stock’s 9-day MACD Oscillator is pointing at 0.10 and 0.04 on the 14-day charts.
In the most recent analyst report for Exelixis Inc. (NASDAQ: EXEL), JMP Securities launched coverage with a Mkt outperform rating. Analysts offering their rating for EXEL stock have a consensus rating for the stock as Overweight. Currently, 1 brokerage advisors rate EXEL as a “sell,”, while 3 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 1 rates the stock as overweight while 11 have offered a “buy” rating.
What is EXEL’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $18.00 and a high of $32.00, with their median price target at $25.00. Looking at these predictions, the average price target given by analysts is for Exelixis Inc. (EXEL) stock is $25.27.